04 June 2024
The Minister of Health of the Russian Federation, Mikhail Murashko, announced that more than 80% of the medications classified as vital and essential (VED) are currently being produced in Russia. Extensive efforts have been made to significantly boost the proportion of domestic drugs in the Russian pharmaceutical market.
“More than 80% of the drugs in the Vital and Essential Drugs list are manufactured within the territory of the Russian Federation,” stated Murashko. ” According to him, more than 550 pharmaceutical production facilities are currently operating in the country, and over the past year, 6 billion packages of medicines were released into civilian circulation, of which 70% were produced in Russia.
Print06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024